Wanbury gets nod to settle debt by selling few brands

03 Jun 2019

Wanbury has received approval for debt settlement and fund raising plan by sale of few brands. The Board of Directors of the Company at its meeting held on June 01, 2019 has approved the same.

Wanbury is the fastest growing pharma company and has a strong presence in the domestic branded formulations.

Related Wanbury Ltd. Links:

Wanbury Share Price

18.45 -0.55 (-2.89%) Dec 11, 13:51
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 430.95
Lupin 744.35
Dr. Reddys Lab 2899.10
Piramal Enterprises 1617.50
Cadila Healthcare 262.35
View more..
Sensex vs Wanbury
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463